Takeda Pharmaceutical Co.’s Thousand Oaks facility hosted a groundbreaking ceremony on July 22, celebrating the $126 million expansion of the facility’s manufacturing capabilities.

The Tokyo-headquartered company’s facility is a vertically integrated bioprocessing plant that specializes in manufacturing products to increase the quality of life for those with rare diseases.

About two years in the making, the $126 million expansion aims to strengthen manufacturing operations. It includes a renovation of about 15,000 square feet of existing space and the addition of another 15,000 square feet of manufacturing space.


Join our Membership to get the full story.

Are you a current Member? Sign In